___________________
OPINION
By Dr Jackson Orem
On the sidelines of the United Nations General Assembly last week, Uganda, represented by Ambassador Robie Kakonge, announced a pioneering pilot initiative aimed at harnessing diaspora remittances to support cancer services across the country. This bold move positions Uganda at the forefront of innovative cancer financing in Africa and globally.
Speaking at the Global Cancer Financing Platform side event, Amb. Kakonge highlighted Uganda’s rich history of leadership in cancer research and treatment. “Uganda has always led the way in cancer innovation, not only in Africa but across the world,” she said. She cited the discovery of Burkitt’s Lymphoma—a cancer that has dramatically advanced global understanding of oncology—as one of the country’s landmark contributions.
Uganda has also been a trailblazer in combination chemotherapy, as well as the development of the essential list of anticancer medicines, a cornerstone of the World Health Organisation’s cancer control efforts. “Today, we are once again taking bold steps by piloting innovative financing solutions for cancer care,” Amb. Kakonge added.
Cancer continues to be one of the fastest-growing health challenges in Uganda. According to robust data from the Kampala Cancer Registry, one of Africa’s longest-standing population-based cancer registries, complemented by nationwide surveillance from the Uganda Cancer Institute (UCI), the country currently records approximately 37,000 new cancer cases and more than 26,000 deaths annually. This mortality burden is particularly high for a population of 51 million, affecting families across Uganda—mothers, fathers, daughters, and sons. Too often, patients are diagnosed at advanced stages, when treatment options are limited and survival chances are slim. However, early detection and timely treatment have proven to dramatically improve outcomes, save lives, and strengthen families and communities.
Amb. Kakonge reaffirmed the commitment of the Government of Uganda, under the leadership of President H.E. Yoweri Kaguta Museveni, to prioritise cancer control. “Our government has established the Uganda Cancer Institute as a statutory agency dedicated to implementing a comprehensive national cancer control programme. Through this institution, there is a dedicated budget for cancer, enabling the development of infrastructure, procurement of equipment and drugs, and the establishment of systems to ensure effective service delivery,” she said.
The UCI provides free cancer treatment to all Ugandans in line with the principles of Universal Health Coverage. This care is also extended to patients from neighbouring countries, including those displaced due to instability or seeking specialised care. Uganda’s designation as a regional centre of excellence for oncology by the East African Community reflects its leadership and commitment to quality cancer care. To further expand access, the government is developing regional cancer centres that will offer comprehensive services closer to the population, including communities along Uganda’s borders, thus improving access for both Ugandans and neighbouring countries.
The highlight of Amb. Kakonge’s address was the announcement of a new pilot initiative to mobilise diaspora remittances for cancer services. Each year, Ugandans abroad send billions of shillings home to support their families. The government aims to leverage a portion of these funds to strengthen cancer screening, diagnostics, and treatment. “Imagine if even a small fraction of the generosity our diaspora shows to their families could also save lives,” she said.
The pilot, developed in partnership with the Global Health Catalyst and the Global Cancer Financing Platform, will test innovative mechanisms for diaspora giving, ensuring funds are used transparently and accountably. “Every shilling must be traceable from commitment to clinic, and every investment must bring us closer to our shared goal of diagnosing and treating cancer earlier,” Amb. Kakonge emphasised. She further noted that the initiative is complementary to government funding, creating an additional channel to strengthen the health system rather than replacing existing investments.
Amb. Kakonge extended an invitation to Ugandans abroad to join the effort, noting that diaspora engagement could play a transformative role in the nation’s fight against cancer. “This is your opportunity to shape a healthier future for Uganda,” she said. She also called on international partners to support Uganda in testing innovative financing approaches that could serve as a model for other countries.
Uganda’s initiative underscores the country’s continued leadership in cancer innovation and commitment to improving health outcomes. By combining domestic investments, regional collaboration, and diaspora support, Uganda aims to create a sustainable, transparent, and effective financing platform for cancer care. As Amb. Kakonge concluded, “We commit to learning openly, sharing our experiences, and building a financing platform that is credible, inclusive, and transformative. Together, we can deliver hope and care for all Ugandans.”
The writer is the Executive Director Uganda Cancer Institute